These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24258459)

  • 1. CHD1L is a novel independent prognostic factor for gastric cancer.
    Su Z; Zhao J; Xian G; Geng W; Rong Z; Wu Y; Qin C
    Clin Transl Oncol; 2014 Aug; 16(8):702-7. PubMed ID: 24258459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CHD1L in bladder cancer and its influence on prognosis and survival.
    Tian F; Xu F; Zhang ZY; Ge JP; Wei ZF; Xu XF; Cheng W
    Tumour Biol; 2013 Dec; 34(6):3687-90. PubMed ID: 23807680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromodomain helicase/ATPase DNA binding protein 1-like protein expression predicts poor prognosis in nasopharyngeal carcinoma.
    Su FR; Ding JH; Bo L; Liu XG
    Exp Ther Med; 2014 Dec; 8(6):1745-1750. PubMed ID: 25371726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer.
    Wu J; Zong Y; Fei X; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
    PLoS One; 2014; 9(8):e98673. PubMed ID: 25153161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
    Mu QJ; Li HL; Yao Y; Liu SC; Yin CG; Ma XZ
    PLoS One; 2015; 10(11):e0143030. PubMed ID: 26599012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis.
    Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD
    Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
    Tang C; Gao X; Liu H; Jiang T; Zhai X
    Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low level of FOXL1 indicates a worse prognosis for gastric cancer patients.
    Ertao Z; Jianhui C; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C; Hui W
    Tumour Biol; 2016 Aug; 37(8):11331-7. PubMed ID: 26960689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of α5β1-integrin is a prognostic marker for patients with gastric cancer.
    Ren J; Xu S; Guo D; Zhang J; Liu S
    Clin Transl Oncol; 2014 Jul; 16(7):668-74. PubMed ID: 24248895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
    Dai W; Ye J; Zhang Z; Yang L; Ren H; Wu H; Chen J; Ma J; Zhai E; Cai S; He Y
    Diagn Pathol; 2018 Oct; 13(1):80. PubMed ID: 30326922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance].
    Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
    Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
    Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
    Guo J; Dong B; Ji JF; Wu AW
    World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression status of cyclase‑associated protein 2 as a prognostic marker for human breast cancer.
    Xu L; Peng S; Huang Q; Liu Y; Jiang H; Li X; Wang J
    Oncol Rep; 2016 Oct; 36(4):1981-8. PubMed ID: 27573674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer.
    Liu C; Fu X; Zhong Z; Zhang J; Mou H; Wu Q; Sheng T; Huang B; Zou Y
    Dig Dis Sci; 2017 Sep; 62(9):2376-2385. PubMed ID: 28646284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of chromodomain helicase DNA binding protein 1-like protein in human solid cancers: A meta-analysis.
    Liu W; Xu J; Zhang C
    Medicine (Baltimore); 2018 Jul; 97(29):e11522. PubMed ID: 30024537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic significance of C/EBP homologous protein (CHOP) in advanced gastric cancer.
    Zhang X; Zhou T; Li W; Zhang T; Che N; Zu G
    Pathol Res Pract; 2018 Aug; 214(8):1105-1109. PubMed ID: 29910063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker.
    Zhang M; Zhang C; Du W; Yang X; Chen Z
    Clin Transl Oncol; 2016 Aug; 18(8):776-81. PubMed ID: 26527032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.